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We analyzed 64 human metapneumovirus strains from
eight countries. Phylogenetic analysis identified two groups
(A and B, amino acid identity 93%–96%) and four sub-
groups. Although group A strains predominated, accounting
for 69% of all strains, as many B as A strains were found in
persons ≥3 years of age.
Studies from various parts of the world have identifiedhuman metapneumovirus (HMPV) as one of the lead-
ing causes of hospitalization for acute respiratory tract
infections in young children (1–5). Severe respiratory
infections associated with HMPV have also been reported
in elderly and immunocompromised persons (6,7). Studies
from our group (6,8) and others (2,5) have identified two
major lineages of HMPV, with some studies indicating the
splitting of those groups into subgroups. Recently, the
complete genomic sequence of a representative strain from
each of the two groups was determined (9). In this study,
our objective was to analyze the fusion (F) gene sequences
of a large set of HMPV strains collected from various
countries over several years and to identify sequence sig-
natures in different HMPV subtypes.
The Study
HMPV sequences included were from isolates grown in
LLC-MK2 (monkey kidney) cells or polymerase chain
reaction (PCR)-amplified products from nasopharyngeal
aspirates (NPA) (1,3,5,6,10). Viral RNA was extracted
from 200 µL of cell culture supernatants or NPA specimens
by using the QIAamp viral RNA Mini Kit (QIAGEN, Inc.,
Mississauga, ON, Canada). For phylogenetic studies,
nucleotide sequences were obtained from amplified
HMPV F-gene products as previously described (6). The
sequence region comprising nucleotides 60–708 of the F
gene was entered into a multiple alignment generated by
Clustal-W and corrected through final visual inspection
with the SeqLab application (Wisconsin package version
10.3, Accelrys Inc., San Diego, CA). Phylogenetic analy-
sis was performed by using distance methods with the
PAUP 4.0b10 program (Sinauer Associates, Inc.,
Sunderland, MA) for the Macintosh. The parameters for
the distance method were Kimura 2-parameters, using the
neighbor-joining algorithm. Five hundred additional boot-
strap analyses were performed on those phylogenetic trees. 
A total of 64 HMPV sequences were analyzed, 34 from
Canada (years 1993–2002) and 30 from various other
countries (years 2000–2002): Peru (n = 2), the United
States (n = 2), France (n = 6), Israel (n = 5), Republic of
South Africa (n = 7), Australia (n = 7), and the prototype
strain 001 (GenBank accession no. AF371337) from the
Netherlands. Phylogenetic analysis of the HMPV F gene
showed the existence of two main groups (A and B) that
could be further subdivided into two subgroups (1 and 2;
Figure 1). Bootstrap analysis strongly supported dividing
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Figure 1. Phylogenetic analysis of the fusion (F) gene of 64 human
metapneumovirus (HMPV) strains recovered from various coun-
tries (CAN, Canada; RSA, Republic of South Africa; FRA, France;
AUS, Australia; NETH, the Netherlands). Neighbor-Joining con-
sensus tree was obtained from the nucleic acid alignment repre-
senting nucleotides 60–708 of the HMPV prototype sequence
NETH-001. Numbers represent the frequency of occurrence of
nodes in 500 bootstrap replicas.
HMPV into the A and B clusters (100% of bootstrap repli-
cas) as well as subdividing them into B1, B2, and A2
(99%–100% of bootstrap replicas). However, the topology
of the tree regarding the A1 subgroup was supported by
only 71% of the bootstrap replicas. This result may be
explained by the strain AUS-2001-4, which could not be
firmly assigned to any of the two A subgroups. In addition,
even though the strain CAN-1993-1 was strongly support-
ed as a member of the A1 group by 91% of the bootstrap
replicas, it was clearly the most divergent, as can be
expected from an older strain.
Identical F-gene sequences (648 nt) were found for
some strains isolated in the same year from the same coun-
try (CAN-1998-5/7, CAN-2000-11/14, CAN-2001-
18/19/20) but also for strains isolated in different years
from different countries (ISRAEL-2002-4 and CAN-1999-
9, FRA-2001-5 and CAN-2002-23/25/27/28/29/32/33/34).
Topology of the phylogenetic tree was also supported by
analysis of homology between sequences. Nucleotide
identity between groups A and B was 81.5%–85.3%,
whereas it was 91.6%–95.3% and 92.0%–94.1% between
subgroups A1–A2 and B1–B2, respectively. The sequences
within the three subgroups A2, B1, and B2 shared a
nucleotide identity of 96.3%–99.0%, 96.0%–99.9%, and
97.2%–99.4%, respectively. The A1 group was the most
divergent; sequences shared 94.4%–99.9% of nucleotide
identity, which was consistent with phylogenetic data.
AUS-2001-4 and CAN-1993-1 strains shared only 94.2%
and 96.5% of nucleotide identity with other members of
the A1 subgroup. At the amino acid level, the identity was
93.1%–96.3% between groups A and B, whereas it was
96.3%–99.1% and 98.1%–99.1% between subgroups
A1–A2 and B1–B2, respectively. Within subgroups, amino
acid identity was 98.2%–100%, 96.8%–100%,
99.5%–100%, and 99.1%–100% for subgroups A1, A2,
B1, and B2, respectively. Based on phylogenetic analysis,
the distance between the two HMPV groups was slightly
smaller than between prototypes from the two respiratory
syncytial virus (RSV) groups (14.5 versus 16.5 substitu-
tions/100 residues, data not shown).
An amino acid alignment of all distinct HMPV F
sequences (representing amino acids 20–233 of the proto-
type strain NETH-001), as well as those of other metap-
neumoviruses and pneumoviruses, is shown in Figure 2.
Cysteine residues were conserved at positions 28, 60, and
182 in all HMPV strains. Analysis of this multiple
sequence alignment showed six amino acid substitutions
found at positions 61, 122, 135, 167, 175, and 233 that may
be used as signature sequences to differentiate group A and
B strains. In addition, we also identified an amino acid
substitution at position 185 that may allow us to differen-
tiate the A1 subtype from others, whereas substitutions
specific to B2 subtypes were located at positions 143 and
179. Some of these substitutions were located in potential
functional domains, such as the fusion domain (codon 122)
and the heptad repeat A (HRA) region (codons 135, 143,
and 167). Two potential N-glycosylation sites were found
in all HMPV sequences.
We investigated associations between HMPV geno-
types and demographic or clinical data, although the small
number of non-Canadian strains limited analyses. Based
on phylogenetic analysis, a total of 44 (68.8%) HMPV
strains were classified in group A (9 [14.1%] A1 and 35
[54.7%] A2), whereas 20 (31.2%) belonged to group B (15
[23.4%] B1 and 5 [7.8%] B2). Group B strains accounted
for 38.2% and 23.3% of Canadian and non-Canadian
strains, respectively (p = 0.20). No B strains were recovered
from France, Australia, and Israel as part of this study. Co-
circulation of both A and B strains was found in Canada
during 2000, 2001, and 2002 as well as in South Africa dur-
ing 2000. Among the 26 HMPV strains recovered before
2001, 57.7% were from group A compared to 42.3% from
group B, whereas the ratios were 76.3% and 23.7% for the
38 strains analyzed in 2001 and 2002 (p = 0.12). When
analysis was restricted to Canadian strains, group A strains
accounted for 46.7% of all HMPV recovered before 2001
and 73.7% of HMPV recovered after 2001 (p = 0.11). All
but one of the recent (year 2001 or later) A strains were
from the A2 subgroup.
Subsequent analyses were performed without the proto-
type strain NETH-001, for which no detailed information
was available. Most strains from the Northern Hemisphere
(41 [87.2%] of 47) and the Southern Hemisphere (11 of
[68.8%]of 16) were recovered over the typical respiratory
virus season, spanning a 5-month period during winter and
spring. Most (69.8%) of the HMPV strains were recovered
from young children ≤3 years, whereas only 25.6% were
from adults >18 years of age, although this finding may
only reflect more intense investigation into viral cases in
children. Group B strains accounted for 25% of total
HMPV strains from study participants ≤3 years of age
compared to 47.4% of those from patients >3 years of age
(p = 0.08). The ratios of group A/group B strains were
62.5%/37.5% for the 32 male and 74.2%/25.8% for the 31
female patients (p = 0.32). Groups A and B strains were
associated with a similar proportion of cases of pneumoni-
tis (12 [27.9%] of 43 vs. 7 [35%] of 20, p = 0.57). Finally,
although group B strains were found in approximately half
of the positive LLC-MK2 cultures (14 [53.8%] of 26),
such strains only represented 16.2% of total HMPV strains
detected by reverse transcription–PCR from NPA samples
(p = 0.002).
Conclusions
Our results, based on a large dataset of viral strains col-
lected over several years from the Northern and Southern
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Hemispheres, confirm two main HMPV groups and at
least four minor subgroups. One strain (AUS-2001-4)
could not be ascribed to one of the two A subtypes and may
constitute a third subtype. We have further demonstrated
that both HMPV genotypes could circulate in a single year
during a typical respiratory virus season, i.e., over the win-
ter and early spring months in countries in both hemi-
spheres. Our phylogenetic data were based on analysis of
the HMPV F protein, one of two viral glycoproteins con-
sidered the major antigenic determinant in RSV (11). Our
data confirm that HMPV is more closely related to avian
pneumovirus type C than to RSV, which is classified in a
separate genus (Pneumovirus) within the same subfamily. 
Overall, the amino acid sequence identity of the two
HMPV F groups was slightly higher than that calculated
for the two RSV groups (93%–96% vs. 89%) (11).
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Figure 2. Amino acid sequence alignment of the fusion (F) protein of various human metapneumovirus (HMPV) strains and other
paramyxoviruses. For full reproduction of this image, please see http://www.cdc.gov/ncidod/EID/ 03-1097-G2.htm Note that only distinct
HMPV strains were included in the alignment. 
Although only the first half of the F gene was sequenced in
this study, our data indicate that all A and B strains can be
easily differentiated on the basis of unique amino acid
changes, some of which are located in functional regions
of the protein, e.g., the putative fusion domain and the
HRA region implicated in paramyxovirus fusion to their
cell receptors. Some of the latter amino acid changes were
nonconservative. Of note, the sequence signatures report-
ed here were also present in two other recent Canadian iso-
lates representing the two major HMPV groups (12).
Additional studies will be required to evaluate the impact
of such changes on pathogenesis and immune response.
Close to 70% of all HMPV strains belonged to group A
with a possible shift towards more A2 strains in recent
years. However, more young children were evaluated in
our study, and the group A genotype infects three times as
many children <3 years of age. In addition, group B
strains, which occurred more frequently in adults, could
have been underestimated, as suggested by the detection of
fewer group B strains in clinical samples (16%) than in
infected LLC-MK2 cells (54%). In that regard, most
HMPV PCR primers designed so far have been selected
from the sequence of strain NETH-001 (which belongs to
group A2 in this study), and consequently, they may not
have been optimal to detect group B strains. Alternatively,
isolating HMPV group A strains may be less efficient in
LLC-MK2 cells. Additional studies are required to validate
these hypotheses. In RSV, group A strains are often
thought to be associated with more severe disease than are
group B strains (13). However, we found no differences in
severity between the two HMPV genotypes when we used
pneumonitis as the clinical endpoint in this small, retro-
spective study.
Our study has some limitations. We analyzed relatively
few non-Canadian strains over a short period of time, con-
sistent with the recent description of this viral pathogen in
2001. Also, much more genetic variability could have been
observed by sequencing the gene encoding for the attach-
ment glycoprotein (G gene) as suggested by RSV and lim-
ited HMPV sequences (14,15). Using different PCR
primers to initially identify HMPV and studying different
populations in the various centers may have also intro-
duced bias in interpreting our results. Nevertheless, our
study confirms the worldwide distribution of HMPV and
provides initial insights into the epidemiology of the two
main viral genotypes.
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